Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected content with an error message. The page retains standard site chrome (navigation/footer), indicating restricted access to the record.SummaryDifference0.5%

- Check21 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study record content and indicating the page is not accessible at this URL.SummaryDifference18%

- Check28 days agoChange DetectedThe revision label on the page updates from v3.6.6 to v3.7.0. This marks a newer version of the page without providing details about content changes.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now shows Revision: v3.6.6, updating from Revision: v3.6.5 to reflect a newer system release.SummaryDifference0.0%

- Check49 days agoChange DetectedThe NIH funding line now includes the year 2017 (U.S. NIH Grant/Contract) in the study's identifiers. This clarifies the funding source associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.